Assessing risk: Does this patient have prostate cancer?

被引：10

作者：

Carter, H. Ballentine ^{[1
]}

机构：

[1] James Buchanan Brady Urol Inst, John Hopkins Sch Med, Baltimore, MD 21287 USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2006年 / 98卷 / 08期

关键词：

D O I：

10.1093/jnci/djj155

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：506 / 507

页数：2

共 12 条

[1] Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer [J].

Carter, HB ;

Epstein, JI ;

Chan, DW ;

Fozard, JL ;

Pearson, JD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18) :1456-1460

[2] LONGITUDINAL EVALUATION OF PROSTATE-SPECIFIC ANTIGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE DISEASE [J].

CARTER, HB ;

PEARSON, JD ;

METTER, J ;

BRANT, LJ ;

CHAN, DW ;

ANDRES, R ;

FOZARD, JL ;

WALSH, PC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (16) :2215-2220

[3] Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy [J].

D'Amico, AV ;

Moul, JW ;

Carroll, PR ;

Sun, L ;

Lubeck, D ;

Chen, MH .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (18) :1376-1383

[4] Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy [J].

D'Amico, AV ;

Chen, MH ;

Roehl, KA ;

Catalona, WJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (02) :125-135

[5] Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer [J].

Draisma, G ;

Boer, R ;

Otto, SJ ;

van der Cruijsen, IW ;

Damhuis, RAM ;

Schröder, FH ;

de Koning, HJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :868-878

[6]

Etzioni R, 2002, J NATL CANCER I, V94, P981

[7] A PROSPECTIVE EVALUATION OF PLASMA PROSTATE-SPECIFIC ANTIGEN FOR DETECTION OF PROSTATIC-CANCER [J].

GANN, PH ;

HENNEKENS, CH ;

STAMPFER, MJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (04) :289-294

[8]

MRYTLE JF, 1989, CLIN ASPECTS PROSTAT, P183

[9] Longitudinal screening for prostate cancer with prostate-specific antigen [J].

Smith, DS ;

Catalona, WJ ;

Herschman, JD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (16) :1309-1315

[10] Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter [J].

Thompson, IM ;

Pauler, DK ;

Goodman, PJ ;

Tangen, CM ;

Lucia, MS ;

Parnes, HL ;

Minasian, LM ;

Ford, LG ;

Lippman, SM ;

Crawford, ED ;

Crowley, JJ ;

Coltman, CA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (22) :2239-2246

← 1 2 →